Medical Company Mergenet Solutions Announces Acquisition of Innomed/Respcare by Salter Labs
Oct 27, 2017
Share this article
COCONUT CREEK, Fla., Oct. 27, 2017 /PRNewswire/ -- Medical and technology Incubator Mergenet Solutions, Inc. announces the acquisition of Innomed Technologies, Inc. and Respcare, Inc. by Illinois based Salter Labs. Mergenet Solutions, Inc. is also parent to Mergenet Medical, Inc.
Innomed Technologies, Inc. and Respcare, Inc. developed and marketed cutting edge sleep apnea therapy interfaces and masks. InnoMed's products include non-invasive ventilation and CPAP masks, including the Aloha and the Nasal Aire II. "Salter's strength in respiratory care and long-standing commitment to improving patient satisfaction were the perfect fit for InnoMed's products," said Shara Hernandez, president of InnoMed Technologies. Mergenet Solutions, Inc. is parent to Mergenet Medical, Inc. Mergenet Medical, Inc. is a developer of HIGH Flow Oxygen Therapy technology as well as other airway and airway secretion devices. About Mergenet Solutions, Inc.
Mergenet Solutions is an established American enterprise with worldwide reach. From an executive home base in Coconut Creek, Florida By functioning as a full-service technology incubator, our organization identifies, assists and invests in new and emerging companies in several promising sectors. Firms at the core of our existing portfolio are involved in cutting-edge advances in technology and breakthrough medical solutions. Learn more at www.mergenetsolutions.com
About Mergenet Medical Inc.
(MMI): Mergenet Medical Inc is a global medical device company that designs and manufactures innovative medical devices that assist healthcare institutions measurably improve outcomes, reduce infections and improve patient and provider safety. Learn more at www.mergenetmedical.com . About InnoMed Technologies, Inc.
InnoMed Technologies, Inc. ( www.innomedinc.com ) is a research-oriented, privately held company that manufactures and markets innovative medical devices to treat obstructive sleep apnea and respiratory insufficiency. InnoMed Technologies, Inc. holds numerous patents with numerous patents pending. InnoMed Technologies Inc. manages and distributes a highly acclaimed line of respiratory and sleep devices, including Nasal-Aire®, Hybrid®, Aloha®, Sylent®, Bravo® and Utopia® line of interfaces. Contact: